Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

Pediatric Blood and Cancer

Volumn 62, Issue 6, 2015, Pages 1078-1080

  Gossai, Nathan ^a   Hilgers, Megan V ^a   Polgreen, Lynda E ^b   Greengard, Emily G ^a  

^a University of Minnesota Children's Hospital   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Denosumab; Giant cell tumor of bone; Hypercalcemia

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; CORTICOSTEROID; CREATININE; DENOSUMAB; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS; VITAMIN D; MONOCLONAL ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR;

ACUTE KIDNEY FAILURE; ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIOPSY; BONE DENSITY; CALCIUM BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYDRATION; HYPERCALCEMIA; LOW DRUG DOSE; LUNG LESION; MINERAL SUPPLEMENTATION; OSTEOCLASTOMA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; SUBCUTANEOUS NODULE; UREA NITROGEN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANTAGONISTS AND INHIBITORS; BONE NEOPLASMS; CHEMICALLY INDUCED; GIANT CELL TUMOR OF BONE; METASTASIS; PATHOLOGY;

ADOLESCENT; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE NEOPLASMS; FEMALE; GIANT CELL TUMOR OF BONE; HUMANS; HYPERCALCEMIA; NEOPLASM METASTASIS; RANK LIGAND;

EID: 84927792230     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25393     Document Type: Article

References (14)

1. Thomas DM, Skubitz KM. Giant cell tumor of bone. Curr Opin Oncol 2009: 21:338-344.
2. Miller IJ, Blank A, Yin SM, McNickle A, Gray R, Gitelis S. A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases. Diagn Pathol 2010: 5:62.
3. Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S. Denosumab in patients with giant cell tumour of bone: An open-label, phase 2 study. Lancet Oncol 2010: 11:275-280.
4. Demirsoy U, Karadogan M, Selek O, Auik Y, Aksu G, Müezzinoglu B, Corapeioglu F. Golden bullet-denosumab: Early rapid response of metastatic giant cell tumor of the bone. J Pediatr Hematol Oncol 2014: 36:156-158.
5. Hakozaki M, Tajino T, Yamada H, Hasegawa O, Tasaki K, Watanabe K, Konno S. Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab. Diagn Pathol 2014: 9:111.
6. Karras N, Polgreen LE, Ogilvie C, Manivel JC, Skubitz KM, Lipsitz E. Denosumab treatment of metastatic giant cell tumor of bone in a 10-year-old girl. J Clin Oncol 2013: 31:e200-e202.
7. Skubitz KM. Giant cell tumor of bone: Current treatment options. Curr Treat Options Oncol 2014: 15:507-518.
8. Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: Interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 2013: 14:901-908.
9. Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 2012: 18:4415-4424.
10. Skubitz KM, Cheng EY, Clohisy DR, Thompson RC, Skubitz AP. Gene expression in giant-cell tumors. J Lab Clin Med 2004: 144:193-200.
11. Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J. Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol 2011: 135:149-158.
12. Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A. Denosumab for post-transplantation hypercalcemia in osteopetrosis. N Engl J Med 2012: 367:1766-1767.
13. Martinez C, Polgreen LE, DeFor TE, Kivisto T, Petryk A, Tolar J, Orchard PJ. Characterization and management of hypercalcemia following transplantation for osteopetrosis. Bone Marrow Transplant 2010: 45:939-944.
14. Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT. Denosumab treatment for fibrous dysplasia. J Bone Miner Res 2012: 27:1462-1470.